Clinical Study of New Intensive Treatment Regimen for Severe Nontuberculous Mycobacterial Pulmonary Disease

NCT05494957 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Nontuberculous Mycobacterial Lung Disease

Interventions

DRUG: New regimen(BdqCfzLzd+XY)

Sponsor

Shanghai Pulmonary Hospital, Shanghai, China

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]